Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Von Willebrand disease"" wg kryterium: Temat


Starter badań:

Tytuł :
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Autorzy :
Baronciani L; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy.
Peake I; Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom.
Schneppenheim R; Department of Pediatric Hematology and Oncology, University Medical Centre, Hamburg-Eppendorf, Hamburg, Germany.
Goodeve A; Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom.
Ahmadinejad M; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran.
Badiee Z; Hemophilia-Thalassemia Center, Mashhad University of Medical Science, Mashad, Islamic Republic of Iran.
Baghaipour MR; Iranian Hemophilia Comprehensive Treatment Centre, Tehran, Islamic Republic of Iran.
Benitez O; Hemophilia Unit, University Vall d'Hebron Hospital, Barcelona, Spain.
Bodó I; Department of Internal Medicine and Hematology-Semmelweis University, Budapest, Hungary.
Budde U; Hemostaseology Medilys Laborgesellschaft mbH, Hamburg, Germany.
Cairo A; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy.
Castaman G; Center for Bleeding Disorders and Coagulation, Careggi University Hospital, Florence, Italy.
Eshghi P; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran.
Goudemand J; Univ. Lille, CHU Lille, Haematology and Transfusion, Lille, France.
Hassenpflug W; Department of Pediatric Hematology and Oncology, University Medical Centre, Hamburg-Eppendorf, Hamburg, Germany.
Hoorfar H; Hemophilia Center, Esfahan University of Medical Science, Esfahan, Islamic Republic of Iran.
Karimi M; Hematology Research Center, Shiraz University of Medical Science, Shiraz, Iran.
Keikhaei B; Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Lassila R; Research Program Unit in Oncology, University of Helsinki, Helsinki University Central Hospital, Coagulation Disorders, Helsinki, Finland.
Leebeek FWG; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Lopez Fernandez MF; Complejo Hospitalario Universitario de A Coruña-Servicio de Hematología y Hemoterapia, A Coruña, Spain.
Mannucci PM; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy.
Marino R; Hemophilia and Thrombosis Centre, University Hospital Policlinico, Bari, Italy.
Nikšić N; Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom.
Oyen F; Department of Pediatric Hematology and Oncology, University Medical Centre, Hamburg-Eppendorf, Hamburg, Germany.
Santoro C; Hematology, Hemophilia and Thrombosis Center, University Hospital Policlinico Umberto I, Rome, Italy.
Tiede A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Toogeh G; Thrombosis Hemostasis Research Center-Vali-Asr Hospital-Emam Khameini Complex Hospital, Tehran University of Medical Science, Tehran, Islamic Republic of Iran.
Tosetto A; Hemophilia and Thrombosis Center, Hematology Department, San Bortolo Hospital, Vicenza, Italy.
Trossaert M; Centre Régional de Traitement de l'Hémophilie-Laboratoire d'Hématologie, Nantes, France.
Zetterberg EMK; Skane University Hospital, Malmo, Sweden.
Eikenboom J; Department of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
Federici AB; Hematology and Transfusion Medicine, L. Sacco University Hospital, Department of Oncology and Oncohematology, University of Milan, Milan, Italy; and.
Peyvandi F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy.; Department of Pathophysiology and Transplantation and Università degli Studi di Milano and Milan and Italy.
Pokaż więcej
Źródło :
Blood advances [Blood Adv] 2021 Aug 10; Vol. 5 (15), pp. 2987-3001.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
von Willebrand Disease, Type 3*/diagnosis
von Willebrand Disease, Type 3*/epidemiology
von Willebrand Disease, Type 3*/genetics
von Willebrand Diseases*
Genotype ; Humans ; Iran/epidemiology ; Prospective Studies
Czasopismo naukowe
Tytuł :
Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.
Autorzy :
Vagrecha A; Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA.; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Stanco J; Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA.
Majeed S; Northwell Health Cancer Institute, Imbert Cancer Center, Bay Shore, NY, USA.
Kouides P; Mary M. Gooley Hemophilia Center, University of Rochester School of Medicine, Rochester, NY, USA.
Acharya SS; Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA.; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Pokaż więcej
Źródło :
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 Jul; Vol. 27 (4), pp. e517-e519. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Anticoagulants/*therapeutic use
COVID-19/*complications
Heparin, Low-Molecular-Weight/*therapeutic use
Thrombosis/*prevention & control
Venous Thromboembolism/*prevention & control
von Willebrand Disease, Type 3/*complications
Aged ; COVID-19/therapy ; Disease Management ; Female ; Humans ; SARS-CoV-2/isolation & purification ; Thrombosis/etiology ; Venous Thromboembolism/etiology ; von Willebrand Disease, Type 3/therapy
Raport
Tytuł :
Von Willebrand disease type 2N: An update.
Autorzy :
Seidizadeh O; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy.
Peyvandi F; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Mannucci PM; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Apr; Vol. 19 (4), pp. 909-916. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hemophilia A*
von Willebrand Disease, Type 2*/diagnosis
von Willebrand Disease, Type 2*/genetics
von Willebrand Diseases*/diagnosis
von Willebrand Diseases*/genetics
Blood Coagulation Tests ; Factor VIII/genetics ; Humans ; von Willebrand Factor/genetics
Czasopismo naukowe
Tytuł :
2B or not 2B? A diagnosis of von Willebrand disease a lifetime of 86 years in the making.
Autorzy :
Chapman K; NSW Health Pathology North, John Hunter Hospital, Newcastle.
Prasad R; Calvary Mater Newcastle, Newcastle.
Mohammed S; NSW Health Pathology West, Institute of Clinical Pathology and Medical Research (ICPMR).
Favaloro EJ; NSW Health Pathology West, Institute of Clinical Pathology and Medical Research (ICPMR).; Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, Sydney.; School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2021 Apr 01; Vol. 32 (3), pp. 229-233.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
von Willebrand Disease, Type 2/*diagnosis
Aged, 80 and over ; Humans ; Male ; Mutation, Missense ; Platelet Aggregation ; Point Mutation ; Polymorphism, Single Nucleotide ; Protein Multimerization ; von Willebrand Disease, Type 2/blood ; von Willebrand Disease, Type 2/genetics ; von Willebrand Factor/analysis ; von Willebrand Factor/genetics
Czasopismo naukowe
Tytuł :
Laboratory variability in the diagnosis of type 2 VWD variants.
Autorzy :
DiGiandomenico S; Department of Pediatrics, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Christopherson PA; Versiti Blood Research Institute, Milwaukee, WI, USA.
Haberichter SL; Department of Pediatrics, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.; Versiti Blood Research Institute, Milwaukee, WI, USA.
Abshire TC; Department of Pediatrics, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.; Versiti Blood Research Institute, Milwaukee, WI, USA.
Montgomery RR; Department of Pediatrics, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.; Versiti Blood Research Institute, Milwaukee, WI, USA.
Flood VH; Department of Pediatrics, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.; Versiti Blood Research Institute, Milwaukee, WI, USA.; Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI, USA.
Pokaż więcej
Corporate Authors :
Zimmerman Program Investigators
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Jan; Vol. 19 (1), pp. 131-138. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
von Willebrand Disease, Type 2*/diagnosis
von Willebrand Disease, Type 2*/genetics
von Willebrand Diseases*
Humans ; Prospective Studies ; Retrospective Studies ; von Willebrand Factor/genetics
Czasopismo naukowe
Tytuł :
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A.
Autorzy :
Campioni M; Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy.
Legendre P; Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche Scientifique, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Loubiere C; Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche Scientifique, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Lunghi B; Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy.
Pinotti M; Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy.
Christophe OD; Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche Scientifique, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Lenting PJ; Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche Scientifique, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Denis CV; Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche Scientifique, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Bernardi F; Department of Life Science and Biotechnology, University of Ferrara, Ferrara, Italy.
Casari C; Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche Scientifique, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Jan; Vol. 19 (1), pp. 139-146. Date of Electronic Publication: 2020 Nov 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Disease Models, Animal*
von Willebrand Disease, Type 2*/genetics
von Willebrand Disease, Type 2*/therapy
von Willebrand Diseases*/genetics
von Willebrand Diseases*/therapy
Animals ; Heterozygote ; Humans ; Mice ; Phenotype ; von Willebrand Factor/genetics
Czasopismo naukowe
Tytuł :
Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding.
Autorzy :
Atiq F; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Wuijster E; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
de Maat MPM; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Kruip MJHA; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Cnossen MH; Department of Pediatric Hematology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Leebeek FWG; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Mar; Vol. 19 (3), pp. 719-731. Date of Electronic Publication: 2021 Jan 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
von Willebrand Disease, Type 1*
von Willebrand Diseases*/diagnosis
von Willebrand Diseases*/epidemiology
Adolescent ; Cohort Studies ; Female ; Humans ; Retrospective Studies ; Risk Factors ; von Willebrand Factor
Czasopismo naukowe
Tytuł :
Type 2N von Willebrand disease: Is it always a recessive trait?
Autorzy :
Woods AI; Laboratory of Hemostasis and Thrombosis, IMEX-CONICET-National Academy of Medicine, Buenos Aires City, Argentina. Electronic address: .
Rossetti LC; Laboratory of Molecular Genetics of Hemophilia, IMEX-CONICET and Hematological Research Institute, National Academy of Medicine, Buenos Aires City, Argentina.
Paiva J; Departament of Hemostasis and Thrombosis, Hematological Research Institute, National Academy of Medicine, Buenos Aires City, Argentina.
De Brasi CD; Laboratory of Molecular Genetics of Hemophilia, IMEX-CONICET and Hematological Research Institute, National Academy of Medicine, Buenos Aires City, Argentina.
Romero ML; Departament of Hemostasis and Thrombosis, Hematological Research Institute, National Academy of Medicine, Buenos Aires City, Argentina.
Casinelli MM; Departament of Hemostasis and Thrombosis, Hematological Research Institute, National Academy of Medicine, Buenos Aires City, Argentina.
Blanco AN; Departament of Hemostasis and Thrombosis, Hematological Research Institute, National Academy of Medicine, Buenos Aires City, Argentina.
Sánchez-Luceros A; Laboratory of Hemostasis and Thrombosis, IMEX-CONICET-National Academy of Medicine, Buenos Aires City, Argentina; Departament of Hemostasis and Thrombosis, Hematological Research Institute, National Academy of Medicine, Buenos Aires City, Argentina.
Pokaż więcej
Źródło :
Thrombosis research [Thromb Res] 2021 Feb; Vol. 198, pp. 49-51. Date of Electronic Publication: 2020 Nov 28.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
von Willebrand Disease, Type 2*
von Willebrand Diseases*/diagnosis
von Willebrand Diseases*/genetics
Humans ; Phenotype ; von Willebrand Factor/genetics
Raport
Tytuł :
Activated factor VIII-mimicking effect by emicizumab on thrombus formation in type 2N von Willebrand disease under high shear flow conditions.
Autorzy :
Yaoi H; Dept. Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Shida Y; Dept. Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Kitazawa T; Chugai Pharmaceutical Co., Research Division, Gotemba, Shizuoka, Japan.
Shima M; Dept. Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
Nogami K; Dept. Pediatrics, Nara Medical University, Kashihara, Nara, Japan. Electronic address: .
Pokaż więcej
Źródło :
Thrombosis research [Thromb Res] 2021 Feb; Vol. 198, pp. 7-16. Date of Electronic Publication: 2020 Nov 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Thrombosis*/drug therapy
von Willebrand Disease, Type 2*
von Willebrand Diseases*
Antibodies, Bispecific ; Antibodies, Monoclonal, Humanized ; Factor VIII ; Factor VIIIa ; Humans ; von Willebrand Factor
Czasopismo naukowe
Tytuł :
Correcting dominant-negative von Willebrand disease.
Autorzy :
Karampini E; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
O'Donnell JS; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.; National Coagulation Centre, St James's Hospital, Dublin, Ireland.; National Children's Research Centre, Our Lady's Children's Hospital, Dublin, Ireland.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Jan; Vol. 19 (1), pp. 55-57.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
von Willebrand Disease, Type 2*
von Willebrand Diseases*/diagnosis
Animals ; Mice ; von Willebrand Factor/genetics
Czasopismo naukowe
Tytuł :
Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease.
Autorzy :
Biguzzi E; A. Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Siboni SM; A. Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
le Cessie S; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Biomedical Datasciences, Section of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.
Baronciani L; A. Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Rosendaal FR; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
van Hylckama Vlieg A; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Peyvandi F; A. Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Jan; Vol. 19 (1), pp. 96-106. Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :
Journal Article
MeSH Terms :
von Willebrand Disease, Type 1*/diagnosis
von Willebrand Diseases*/diagnosis
Factor VIII/*analysis
von Willebrand Factor/*analysis
Adolescent ; Adult ; Humans ; Young Adult
Czasopismo naukowe
Tytuł :
[von Willebrand disease type 2B caused by gene mutation in a newborn].
Autorzy :
Ma JY; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Chen ZP; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Li G; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Gu H; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Wu RH; Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Pokaż więcej
Źródło :
Zhonghua er ke za zhi = Chinese journal of pediatrics [Zhonghua Er Ke Za Zhi] 2021 Mar 02; Vol. 59 (3), pp. 233-235.
Typ publikacji :
Journal Article
MeSH Terms :
von Willebrand Disease, Type 2*
von Willebrand Diseases*
Blood Platelets ; Humans ; Infant, Newborn ; Mutation
Czasopismo naukowe
Tytuł :
Case Report: An Infant with Severe Thrombocytopenia Diagnosed with Type 2B von Willebrand Disease Due To a De Novo p.Val1316Met Mutation
Autorzy :
Fan J; Children’s Hospital of Soochow University, Department of Hematology and Oncology, Jiangsu, China
Ling J; Children’s Hospital of Soochow University, Department of Hematology and Oncology, Jiangsu, China
Zhou H; Children’s Hospital of Soochow University, Department of Hematology and Oncology, Jiangsu, China
He J; Children’s Hospital of Soochow University, Department of Hematology and Oncology, Jiangsu, China
Hu S; Children’s Hospital of Soochow University, Department of Hematology and Oncology, Jiangsu, China
Pokaż więcej
Źródło :
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2020 Nov 19; Vol. 37 (4), pp. 296-298. Date of Electronic Publication: 2020 Jul 03.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Amino Acid Substitution*
Codon*
Mutation*
Thrombocytopenia/*diagnosis
von Willebrand Disease, Type 2/*diagnosis
von Willebrand Disease, Type 2/*genetics
von Willebrand Factor/*genetics
Alleles ; Blood Coagulation ; Blood Coagulation Tests ; DNA Mutational Analysis ; Diagnosis, Differential ; Female ; Genotype ; High-Throughput Nucleotide Sequencing ; Humans ; Infant, Newborn ; Thrombocytopenia/blood ; von Willebrand Disease, Type 2/blood
Czasopismo naukowe
Tytuł :
Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study.
Autorzy :
Tosetto A; Hemophilia and Thrombosis Center, Hematology Department, San Bortolo Hospital, Vicenza, Italy.
Badiee Z; Hemophilia-Thalassemia Center, Mashhad University of Medical Science, Mashad, Islamic Republic of Iran.
Baghaipour MR; Iranian Hemophilia Comprehensive Treatment Centre, Tehran, Islamic Republic of Iran.
Baronciani L; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milan, Italy.
Battle J; Complejo Hospitalario Universitario de A Coruña-Servicio de Hematología y Hemoterapia, A Coruña, Spain.
Berntorp E; Skane University Hospital, Malmo, Sweden.
Bodó I; Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Budde U; MEDILYS Labor Gesellschaft, Hamburg, Germany.
Castaman G; Center for Bleeding Disorders and Coagulation, Careggi University Hospital, Florence, Italy.
Eikenboom JCJ; Division of Thrombosis and Hemostasis, Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Eshghi P; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran.
Ettorre C; Hemostasis and Thrombosis Center, Azienda Ospedaliera Policlinico Consorziale, Bari, Italy.
Goodeve A; University of Sheffield, Sheffield, UK.
Goudemand J; Department of Haematology Transfusion, University Lille-CRMW, CHRU Lille, Lille, France.
Hay CRM; Manchester Royal Infirmary, Manchester, UK.
Hoorfar H; Hemophilia Center-Esfahan University of Medical Science, Esfahan, Islamic Republic of Iran.
Karimi M; Hematology Research Center, Nemazee Hospital, Shiraz University of Medical Science, Shiraz, Islamic Republic of Iran.
Keikhaei B; Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Lassila R; Coagulation Disorders, Helsinki University Central Hospital, Helsinki, Finland.
Leebeek FWG; Erasmus Medical Center, Rotterdam, the Netherlands.
Lopez Fernandez MF; Complejo Hospitalario Universitario de A Coruña-Servicio de Hematología y Hemoterapia, A Coruña, Spain.
Mannucci PM; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milan, Italy.
Mazzucconi MG; Hemophilia and Thrombosis Center-University of Rome, Rome, Italy.
Morfini M; Center for Bleeding Disorders and Coagulation, Careggi University Hospital, Florence, Italy.
Oldenburg J; Institute of Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany.
Peake I; University of Sheffield, Sheffield, UK.
Parra Lòpez R; Unidad de Hemofilia-Hospital Universitari General Vall d'Hebron, Barcelona, Spain.
Peyvandi F; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Schneppenheim R; Department of Pediatric Hematology and Oncology, University Medical Centre, Hamburg, Germany.
Tiede A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Toogeh G; Thrombosis Hemostasis Research Center-Vali-Asr Hospital-Emam Khameini Complex Hospital, Tehran University of Medical Science, Tehran, Islamic Republic of Iran.
Trossaert M; Centre Régional de Traitement de l'Hémophilie-Laboratoire d'Hématologie, Nantes, France.
Zekavat O; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran.
Zetterberg EMK; Skane University Hospital, Malmo, Sweden.
Federici AB; Hematology and Transfusion Medicine, Department of Oncology and Oncohematology, L. Sacco University Hospital, University of Milan, Milano, Italy.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Sep; Vol. 18 (9), pp. 2145-2154. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
von Willebrand Disease, Type 1*/diagnosis
von Willebrand Disease, Type 3*/diagnosis
von Willebrand Disease, Type 3*/epidemiology
von Willebrand Diseases*/diagnosis
von Willebrand Diseases*/epidemiology
Cross-Sectional Studies ; Female ; Hemarthrosis ; Humans ; von Willebrand Factor
Czasopismo naukowe
Tytuł :
How I treat von Willebrand disease.
Autorzy :
Castaman G; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy. Electronic address: .
Pokaż więcej
Źródło :
Thrombosis research [Thromb Res] 2020 Dec; Vol. 196, pp. 618-625. Date of Electronic Publication: 2020 Aug 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Hemophilia A*
von Willebrand Disease, Type 1*
von Willebrand Diseases*/diagnosis
von Willebrand Diseases*/drug therapy
Deamino Arginine Vasopressin/therapeutic use ; Factor VIII ; Hemorrhage ; Humans ; von Willebrand Factor
Czasopismo naukowe
Tytuł :
Use of Tranexamic Acid for the Treatment of Mittelschmerz in a Patient with Type 1 von Willebrand Disease and Recurrent Hemorrhagic Cysts.
Autorzy :
Lasry A; Department of Obstetrics and Gynecology, McGill University, Montréal, QC.
Gil Y; Department of Obstetrics and Gynecology, McGill University, Montréal, QC.
Balayla J; Department of Obstetrics and Gynecology, McGill University, Montréal, QC. Electronic address: .
Pokaż więcej
Źródło :
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC [J Obstet Gynaecol Can] 2020 Nov; Vol. 42 (11), pp. 1385-1387. Date of Electronic Publication: 2020 Mar 24.
Typ publikacji :
Case Reports
MeSH Terms :
Cysts*
Hemorrhage*
Pain/*etiology
Pelvic Pain/*etiology
Tranexamic Acid/*therapeutic use
von Willebrand Disease, Type 1/*complications
Adult ; Female ; Humans ; Ovulation ; Pain/diagnosis ; Treatment Outcome ; von Willebrand Disease, Type 1/drug therapy ; von Willebrand Diseases
Raport
Tytuł :
Risk of perinatal intracranial hemorrhage and role of prenatal genetic testing in individuals with type 3 von Willebrand disease.
Autorzy :
Warad D; Special Coagulation Laboratory, Division of Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.; Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Ismail M; Mayo Medical School, Mayo Clinic, Rochester, Minnesota, USA.
Rusk D; Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Rodriguez V; Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Pruthi RK; Special Coagulation Laboratory, Division of Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Oct; Vol. 18 (10), pp. 2779-2780.
Typ publikacji :
Letter; Comment
MeSH Terms :
von Willebrand Disease, Type 3*
von Willebrand Diseases*/diagnosis
von Willebrand Diseases*/genetics
Cross-Sectional Studies ; Female ; Genetic Testing ; Humans ; Intracranial Hemorrhages/diagnosis ; Intracranial Hemorrhages/genetics ; Pregnancy
Opinia redakcyjna
Tytuł :
Involvement of von Willebrand factor and botrocetin in the thrombocytopenia induced by Bothrops jararaca snake venom.
Autorzy :
Thomazini, Camila Martos (AUTHOR)
Sachetto, Ana Teresa Azevedo (AUTHOR)
de Albuquerque, Cynthia Zaccanini (AUTHOR)
de Moura Mattaraia, Vânia Gomes (AUTHOR)
de Oliveira, Ana Karina (AUTHOR)
Serrano, Solange Maria de Toledo (AUTHOR)
Lebrun, Ivo (AUTHOR)
Barbaro, Katia Cristina (AUTHOR)
Santoro, Marcelo Larami (AUTHOR)
Pokaż więcej
Źródło :
PLoS Neglected Tropical Diseases. 9/3/2021, Vol. 15 Issue 9, p1-21. 21p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies